Medical Imaging

News on medical imaging technologies and applications.

Androvia LifeSciences has developed a predictive biomarker test that some clinicians are using to determine a man's fertility.   

CDx Diagnostics reported that crypt dysplasia, identified and analyzed using its three-dimensional detection and surveillance system, could present a risk for esophageal cancer.

The mobile approach enables stroke patients to be assessed within the three-hour window for stroke treatment.

The firm will use the funds to expand deployment of its digital pathology software and accelerate use of artificial intelligence applications.

The microfluidics- and machine vison-based diagnostic may improve risk stratification of patients and reduce overtreatment, according to the company.